Abstract
Telomerase deficiency induces early senescence and defects in proliferating cell populations, but in mice it has not been associated with inflammatory bowel disease. Genetically engineered mice lacking either telomerase reverse transcripase (TERT-KO) or telomerase RNA (TR-KO) were examined for chronic diarrhea and wasting. Affected mice had pasty stools, thickened, non-distensible colon walls, and contracted ceca. Histologically, the cecal mucosa was largely replaced by inflammatory infiltrate consisting of plasma cells, neutrophils, lymphocytes, and macrophages with marked widespread fibrosis and ulceration. Remaining epithelium was disorganized and hyperplastic, with multifocal dysplasia. Colonic mucosa was markedly hyperplastic with similar inflammation and epithelial dysplasia. Multifocal adenomatous hyperplasia, but no inflammation, was present in the small intestine. Microaerophilic spiral bacteria with 16S rRNA gene sequences identical to Helicobacter mastomyrinus were isolated from the colon and cecum.
Severe granulomatous typhlocolitis without epithelial dysplasia developed in germ-free recombination-activating gene (RAG)-KO recipients of CD4+ T cells and inoculated with cecal contents from affected TERT-KO mice, and in SPF recipient RAG-KO mice and IL-10 KO mice inoculated with H. mastomyrinus. Typhlocolitis in mice given H. mastomyrinus was more severe than in mice given H. hepaticus.
Telomerase-deficient mice are susceptible to helicobacter-associated typhlocolitis. H. mastomyrinus causes severe disease in susceptible mouse strains.
Keywords: Adoptive transfer, Cecum, Colon, Helicobacter mastomyrinus, IL-10, Inflammatory bowel disease, Mice, Telomerase
Murine enterohepatic helicobacters are now generally recognized as opportunistic pathogens that cause hepatitis, typhlocolitis, and hepatic and colonic neoplasia in susceptible mouse strains 17,35,53. There remains considerable controversy regarding the role of these organisms as primary pathogens, however, and the relative pathogenicity of different helicobacter species is not well studied. Of the 11 species of enterohepatic helicobacter species thus far identified in rodents, H. hepaticus is the most commonly isolated, and best studied. It was first identified in association with hepatitis and hepatic carcinoma in A/J mice 50,53, and has been shown to be associated with typhlocolitis in a number of mouse strains that have altered immune function 8,9,16,18,29,31,51. Other species associated with inflammation of the lower bowel in mice include H. typhlonicus, 11,20 H. bilis, 44 H. muridarum, 25H. rodentium, 11,43, H. trogontum, 54 and H. ganmani 58, but there are few comparative studies on the pathogenicity of different helicobacter species. In addition, some studies have described inflammatory bowel disease in mice in the absence of detectable helicobacters, 13,21 and others have implicated non-helicobacter species in lower bowel inflammation. 2,40 Thus, there remains considerable debate as to whether or not these organisms are primary pathogens, and they are not routinely eliminated in some mouse colonies. In fact, a recent survey revealed the presence of one or more helicobacter species in 88% of 34 institutions world-wide 47, suggesting that concern regarding elimination of these organisms remains low.
In addition to their role in naturally-occurring disease in infected colonies, lower bowel helicobacters have attracted interest as models of inflammatory bowel disease (IBD) in humans. The best studied of these models are IL-10 KO mice 7,29,54 and severe, combined immunodeficient (SCID) or recombination-activating gene (RAG) KO mice that are adoptively transferred with CD4+ effector T cells from congenic mice (recipient RAG KO or SCID mice) 25,28. Both of these models lack regulatory T cell function, and both develop severe typhlocolitis in response to H. hepaticus and several other enteric murine helicobacters. Study of these as well as several other models involving mutant mouse strains and lower bowel helicobacters has indicated that a common factor in susceptibility to helicobacter-associated inflammatory bowel disease in mice is defective immunoregulation, and that severe inflammation may in some cases lead to neoplastic transformation (for reviews, see 46,55). Thus, these models are of interest in the investigation of the role of immune dysfunction and bacterial colonization in IBD and colon cancer in humans.
In this report we describe a spontaneous outbreak of severe inflammatory lower bowel disease in telomerase-deficient mice. A single helicobacter species, H. mastomyrinus, was identified in affected mice, and both IL-10 KO mice and recipient RAG-KO mice developed severe typhlocolitis when inoculated with H. mastomyrinus from telomerase-deficient mice.
Methods
Mice
Telomerase-deficient mice were from the breeding colony at the University of Michigan and were kindly supplied by Dr. Sem Phan. The colony was established in 2003 and sentinels were screened quarterly for mouse pathogens by the University of Michigan Unit for Laboratory Animal Medicine (for a list of pathogens, see: http://ulam.med.umich.edu/services/healthcare/surveillance.html), The University of Michigan does not routinely screen for helicobacter. Two mutant mouse strains were examined. Telomerase reverse transcriptase (TERT)-KO mice were engineered to contain a partial deletion of the telomerase reverse transcriptase gene 32,57. These mice expressed telomerase RNA (mTR) but not telomerase enzyme. Telomerase RNA (TR)-KO mice 5 lacked the telomerase RNA component, but carried wild-type TERT. Both mouse strains were functionally telomerase-deficient, 5,57, were on a C57BL/6 background, and were routinely maintained by breeding of heterozygotes. On some occasions, homozygotes were bred, but offspring of homozygote matings were not used as breeders. Thus, in all cases mice were offspring of heterozyote matings or first generation offspring of homozyogote matings. The mice were maintained in microisolator cages and fed standard rodent chow and water ad libitum. No experimental procedures were performed on any of the mice. Sick mice were submitted to the pathology service of the Unit for Laboratory Animal Medicine for necropsy. The genotype, sex and age distribution of the mice available for examination is indicated in table 1.
Table 1.
Age and sex distribution of TERT-KO and TR-KO mice available for examination
| Straina | Sex | Age and number of mice in group
|
|||
|---|---|---|---|---|---|
| 1–2 months | 3–5 months | 6–12 months | >12 months | ||
| TERT-KO | F | 1 | 8 | 46 | 0 |
| TERT-KO | M | 2 | 7 | 3 | |
| mTR-KO | F | 8 | 2 | ||
| mTR-KO | M | 2 | |||
| TERT-het | F | 11 | 1 | 9 | |
| TERT-het | M | 6 | 3 | ||
| mTR-het | F | 5 | |||
| mTR-het | M | 3 | |||
TERT = telomerase reverse transcriptase; mTR= murine telomerase RNA; KO=knockout; het=heterozygote
Male and female germ free RAG-1 KO mice on a C57BL/6 background were from the University of Michigan Germ Free Life Laboratory. They were maintained in sterile bubble isolators and remained bacteriologically sterile until removed from the isolators and inoculated with cecal contents. Germ free mice were conventionalized by oral inoculation with feces from normal helicobacter-free C57BL/6 mice (Jackson laboratories), and removal to microisolator housing. IL-10 KO and congenic C57BL/6 mice were from the University of Michigan breeding colony, housed separately from the telomerase-deficient mice and were helicobacter-free as determined by PCR screening. All mice were on a C57BL/6 background. All animal experiments were approved by the University of Michigan Committee on Use and Care of Animals.
Bacterial culture and inoculation
For primary isolation of helicobacter from feces, colon, or cecum, fresh samples were homogenized in 500 μl of trypticase soy broth, passed through a 0.45μm syringe filter, collected in a sterile tube, and streaked onto TSA-CVA plates (trypticase soy agar, 5% sheep blood, 20 μg/ml cefoperazone, 10 μg/ml vancomycin, 2 μg/ml amphotericin B). The culture was incubated at 37 C under microaerobic conditions for 10 days and cultures were identified as H. mastomyrinus by culture morphology, microscopic examination, and cloning and sequencing of the 16S rRNA gene. H. mastomyrinus strains AY742307 and AY631955, kindly supplied by Dr. Jim Fox, were used for comparisons. Microaerobic conditions were generated as previously described 37 by evacuation of vented GasPak jars without a catalyst after evacuation to 20 mm Hg and equilibration with a gas mixture consisting of 80% N2, 10% CO2, and 10% H2.
H. mastomyrinus isolated from TERT KO mice and H. hepaticus strain 3B1(ATCC 51449) were cultured as described above on trypticase soy agar plates containing 5% sheep blood without antibiotic supplement. For mouse inoculation, cultures were incubated as above for 4 days, and bacteria were scraped from plates and resuspended in trypticase soy broth (TSB) to an OD of 1.0 at 600 nm (approximately 108 CFU/ml). Mice were inoculated orally with 0.15 ml of the bacterial suspension or with sterile TSB. Bacteria recovered from feces or cecal contents of infected mice were identified as H. mastomyrinus or H. hepaticus by culture morphology, microscopic examination, PCR, restriction-fragment length polymorphism (RFLP) analysis, and sequencing (H. mastomyrinus only).
DNA isolation and PCR
To identify bacteria in cecum, colon, or feces, genomic DNA was extracted with the DNeasy Blood & Tissue kit (Qiagen) using a modified protocol. Modifications included (i) adding a bead-beating step using UltraClean fecal DNA bead tubes (Mo Bio Laboratories, Inc.) that were shaken using a Mini-Beadbeater-8 (BioSpec Products, Inc.) at the “homogenize” setting for 1 min, (ii) increasing the amount of buffer ATL used in the initial steps of the protocol (from 180 μl to 360 μl), (iii) increasing the volume of proteinase K used (from 20 μl to 40 μl), and (iv) decreasing the amount of buffer AE used to elute the DNA at the end of the protocol (from 200 μl to 100 μl).1 DNA was amplified with conserved 16S rRNA helicobacter genus specific primers (C05: 5′ ACT TCA CCC CAG TCG CTG 3′, and C97: 5′ GCT ATG ACG GGT ATC C 3′) 42. The cloning reaction was performed as described previously 27 with illustra PuReTaq Ready-To-Go PCR beads (GE Healthcare, Piscataway, NJ). Each 25 μl PCR mixture contained 20 pmol of each primer, 200 μM of each deoxynucleoside triphosphate, and 1.5 U of Taq DNA polymerase in a final concentration of 10 mM Tris-HCl, 50 mM KCl, and 1.5 mM MgCl2. To identify cultured bacteria, DNA was extracted using the Invitrogen Easy-DNA kit per the manufacturers instructions, and amplified with helicobacter genus-specific primers C05 and C97 (above), and with species-specific primers (C60: 5′ AGA ACT GCA TTT GAA ACT ATG AG 3′, C61: 5′ CAG TAT TGC GTC TCT TTG TA 3′) 42.
Bacteria in situ were identified by cloning and sequencing of PCR products. For this, PCR amplicons were purified using the illustra MicroSpin S-400 HR columns (GE Healthcare) as directed by the manufacturer. Purified products were ligated into the TOPO 4® vector (Invitrogen K4575-01, Carlsbad, CA) according to manufacturer’s specifications, and transformed into Escherichia coli. Individual colonies were picked following overnight incubation on LB plates with carbenicillin (50 μg/ml) then cultured overnight in Luria Broth freeze media with carbenicillin (50 μg/ml). Vector specific primers (M13F: 5′-CAGTCACGACGTTGTAAAACGACGGC-3′; and M13R: 5′-CAGGAAACAGCTATGACCATG-3′) were used to screen these colonies for bacterial clones containing the appropriate 1.2 Kb amplicon insert. Clones were sequenced with M13F and M13R primers at the University of Michigan’s Sequencing Core.
Bacterial cultures were identified by RFLP fingerprinting and by sequencing of PCR amplicons. For RFLP fingerprinting, amplicons from the genus specific primers (1.2 kb), were digested with HhaI. H. hepaticus yielded three bands of 150, 250 and 800 base pairs. H. mastomyrinus yielded three bands of 300, 400 and 600 bp, as described by Shen et al 42. For sequencing, species-specific amplicons were submitted to the Sequencing Core at the University of Michigan. The sequences were assessed for quality, trimmed, aligned and classified using the online tools of the Ribosomal Database Project (http://rdp.cme.msu.edu). 12,49
Immunochemistry
Identity of inflammatory cells in formalin-fixed, paraffin-embedded sections was determined by morphology in HE-stained sections and by immunoreactivity to CD3 (T cells), CD45R/B220 (B cells), F4/80 (macrophages) or IRF-4 (plasma cells) 52. Immunostaining was performed on an automated immunostainer (Biocare Intellipath). Antigen retrieval for macrophage detection was performed by 10 minutes trypsin digestion (Biocare Medical, Concord, CA) at room temperature. Retrieval for T, B, and plasma cells was performed by heat-induced retrieval at 95 C in a decloaking chamber (Biocare) using commercial solutions (T cells: Biocare Diva, B cells: Biocare Rodent Decloaker, plasma cells: Biogenex Citrate buffer, San Ramon, CA). T cells were labeled with rabbit monoclonal anti-CD3 (Thermo-scientific, RM9107-S, Waltham, MA) at 1:500 with 1 hour incubation. B cells were labeled with rat monoclonal anti-CD45R/B220 (BD Biosciences, 550286, San Jose, CA) at 1:200 for 30 minute incubation. Macrophages were labeled with rat monoclonal anti-F4/80 (Abcam, ab6640, Cambridge, MA) at 1–100 with 1 hour incubation. Plasma cells were labeled with goat polyclonal anti-IRF-4 (Santa Cruz Biotechnology, sc-6059) at 1–500 with 1 hour incubation. Immunodetection was by a horseradish peroxidase-conjugated polymer system with diaminobenzidine for rat and rabbit primary antibodies (Biocare Promark series, Rat-on-Rodent, Rabbit-on-Rodent) and an alkaline phosphatase-conjugated polymer system (Biocare Goat Polymer detection) with Biocare Vulcan fast red for goat antibodies. Negative controls were naïve serum from the species of the primary antibody. Sections were counterstained with hematoxylin.
Transmission experiments
For determination of bacterial pathogenicity, three groups of mice were used: Germ-free RAG KO mice removed from the sterile germ free isolators and inoculated with cecal contents from TERT-KO mice; germ free RAG KO that had been conventionalized by removal from the germ free isolators and housed in specific pathogen free conditions for 30 days prior to inoculation with H. mastomyrinus isolated from telomerase-deficient mice or with H. hepaticus strain 3B1; and IL-10 KO mice inoculated with H. mastomyrinus or H. hepaticus. Two weeks following bacterial inoculation, RAG KO mice were inoculated intraperitoneally with 106 CD4+ enriched splenocytes from C56BL/6 mice. CD4+ cell enrichment was performed by magnetic bead separation as previously described 14. Cells isolated in this way contain >95% CD4+ cells and B cells and CD8+ T cells are below the limit of detection. Control mice were either uninfected or untransferred. Mouse groups and the number of mice per group are indicated in table 2.
Table 2.
Mouse groups experimentally inoculated with helicobacter
| Mouse strain | Bacterial inoculum | N | DPIa |
|---|---|---|---|
| Germ free RAG KO | Cecal contents from telomerase-deficient mice | 15 | 56 |
| Conventionalized RAG KO | H. mastomyrinus | 3 | 56 |
| Conventionalized RAG KO | H. hepaticus | 4 | 56 |
| Conventionalized RAG KO | None | 9 | 56 |
| C57BL/6 | H. hepaticus | 3 | 27 |
| C57BL/6 | H. mastomyrinus | 6 | 27 |
| C57BL/6 | None | 3 | 27 |
| IL-10 KO | H. hepaticus | 4 | 12 or 27 |
| IL-10 KO | H. mastomyrinus | 10 | 12, 15, or 27 |
| IL-10 KO | None | 9 | 12, 15, or 27 |
DPI=days post-inoculation
Tissue collection
Telomerase-deficient KO and heterozygous mice were euthanized either when severe diarrhea was noted or as age-matched controls. Experimentally-infected mice were euthanized at intervals indicated in table 2. At necropsy of telomerase-deficient and heterozygous control mice, gross lesions were recorded and sections of all levels of intestinal tract, as well as kidney, liver, lung, heart, and spleen were immersion-fixed in 10% neutral buffered formalin and embedded in paraffin. Five micron sections were stained with hematoxylin and eosin or Warthin-Starry silver stain, and examined for the presence or absence of morphologic lesions or bacteria in the intestinal lumen. Cecal contents and feces were collected for culture and PCR identification of helicobacter.
At necropsy of experimentally-infected mice, stomach, small intestine, cecum, and colon were immersion-fixed in 10% neutral buffered formalin and embedded in paraffin. Cecum was emptied of contents and embedded in its entirety with the ileocecal junction towards the surface of the block. Sections of proximal, middle, and distal colon were embedded and cut in longitudinal section. Five micron sections were stained with hematoxylin and eosin or Warthin-Starry silver stain and lesions were semi-quantified as described below.
Histologic scoring
Sections of colon and cecum from experimentally-infected mice were scored for severity of lower bowel inflammation, as indicated in table 3. All sections were coded and scored blind. Lesions scored were: mucosal hypertrophy and hyperplasia, neutrophilic infiltrate, mononuclear inflammatory infiltrate (lymphocytes, plasma cells, or histocytes), and adenitis, defined as dilation of glands with cellular debris and neutrophils. Severity was estimated on a scale of 0–3, as shown in table 3. In addition, the presence or absence of serositis (indication of transmural inflammation) was recorded and scored as absent (0) or present (1), and organized mucosal lymphoid follicles (MALT) were scored as absent (0), present (1), or hyperplastic (2). The total score for each section was determined by adding the scores for the individual lesions.
Table 3.
Histologic scoring of cecum and colon of experimentally-infected mice.
| Scorea | Epithelial hyperplasia | PMN | Mononuclear inflammatory cellsb | Adenitis | MALT | Serositis |
|---|---|---|---|---|---|---|
| 0 | Absent | Absent | Absent | Absent | Absent | Absent |
| 1 | Detectable | Mild and focal or multifocal | Mild and focal or multifocal | Mild and focal or multifocal | Present | Present |
| 2 | Moderate | Moderate and multifocal or widespread | Moderate and multifocal or widespread | Moderate and multifocal or widespread | Hyperplastic | |
| 3 | Marked | Severe, and widespread | Severe, and widespread | Severe, and widespread |
Total score is the score for each criterion added together (Max score =15)
Lymphocytes, plasma cells, and histiocytes were scored together as mononuclear inflammatory cells
Statistics
Groups were compared by Mann-Whitney U test (2 groups) or by ANOVA with Bonferroni corrections for multiple groups. Error bars in charts indicate standard error of the mean.
Results
Wasting and typhlocolitis in telomerase-deficient mice
Affected mice appeared thin with little body fat and wasted musculature. Mean body weight in female TERT-KO mice, the only group that contained enough control mice for comparison, was significantly less than in age-matched heterozygous controls (figure 1). Grossly, ceca in affected mice were small and firm with thickened walls and minimal to absent lumens. (figure 2). In contrast to unaffected heterozygous controls (figure 3), colons of affected mice were distended with soft, pasty stools, and had thickened walls. Gross lesions were confined to the large intestine, except that one mouse had unilateral hydronephrosis, considered to be a background lesion in C57BL/6 mice. Heterozygous controls had no gross lesions.
Figure 1.

Body weights of TERT-KO and heterozygous control mice. Mice were weighed immediately following euthanasia. Each symbol represents one mouse. KO=TERT knockout, het= heterozygous control.
Figure 2–13.
Figure 2. Cecum and colon from a TERT-KO mouse. The cecum is contracted, firm, and empty (arrow), the colon and cecal walls are thickened, and the colon contains soft, pasty stool (arrowheads).
Figure 3. Cecum and colon from an unaffected heterozygous control mouse. The cecum is of normal size and the colon contains formed feces.
Figure 4. Cecum of affected TERT-KO mouse. The cecal wall is thickened with inflammatory infiltrate, hyperplastic mucosa-associated lymphoid tissue (arrows), and fibrous connective tissue. HE.
Figure 5. Cecum from an unaffected TERT heterozygous mouse at the same magnification as figure 4. Inflammation is absent. HE.
Figure 6. Cecum from a TERT KO mouse showing replacement of the mucosa by chronic inflammatory infiltrate consisting of granulocytes and mononuclear and multinuclear plasma cells. A retained dysplastic gland is present (arrow). HE
Figure 7. Cecum from a TERT KO mouse. Higher magnification of figure 6 showing dense plasmacytic infiltrate Inset: Multinucleated plasma cell. HE
Figure 8. Cecum from a TERT KO mouse. Higher magnification of figure 6 showing neutrophils and fibrosis in the ulcer crater. HE
Figure 9. Cecum from a TERT KO mouse. Dysplastic glands demonstrate irregular piling up of epithelium with anisocytosis, anisokaryosis, and mild dysplasia. HE
Figure 10. Cecum from a TERT KO mouse. Silver-positive, elongated narrow spiral organisms are present within a cecal gland. Warthin-Starry.
Figure 11. Cecum from a TERT KO mouse. CD3+ cells (a) and CD45R (B220)+ cells (b) are present in association with mucosal lymphoid follicles. IRF-4+ plasma cells (c) account for most of the remaining cells in the lamina propria and submucosa. Inset shows nuclear and cytoplasmic immunoreactivity of both mononuclear and multinuclear plasma cells. There is background staining of most infiltrating lamina propria cells with F4/80 (Interpreted as artifactual, d), and only a few cells have strong membrane staining compatible with macrophages (inset). Immunoperoxidase reaction with DAB (a, b, d) or fast red (c) chromogen and Harris’ hematoxylin counterstain.
Figure 12. Jejunum from a TERT KO mouse showing multifocal adenomatous hyperplasia,. HE.
Figure 13. Jejunum from an unaffected heterozygote control mouse. Adenomatous hyperplasia is absent. HE.
Histologically, the cecal walls were markedly thickened and the epithelium was largely replaced by inflammatory infiltrate, mucosal lymphoid follicles, and fibrous connective tissue (figure 4). The cecal lumens were markedly reduced in size compared to control mice (figure 5). Typhlitis was characterized by severe transmural inflammation (figure 6) consisting of primarily of numerous activated plasma cells that were occasionally binucleate or multinucleate (figure 7), granulocyctes (mostly neutrophils with a few eosinophils, figure 8), and fewer macrophages and lymphocytes. Similar infiltrate was present extending into the surrounding serosa and within local lymph nodes. In some mice there was granulocytic hyperplasia of splenic hepatopoietic tissue.
The epithelium was largely absent, and replaced by fibrosis and inflammation, with only a few retained proliferative epithelial nodules (figure 6). In addition to ulceration and loss of glands, epithelial changes included widespread proliferation characterized by piling up of nuclei and many mitotic figures. Focal epithelial dysplasia was present in some proliferating glands, and was characterized by loss of cell polarity, anisocytosis, anisokaryosis, and cellular atypia (figure 9). Remnant proliferating glands were often dilated with necrotic cellular debris. In the colons there was marked epithelial hyperplasia and chronic neutrophilic inflammation, but epithelial dysplasia and ulceration were less prominent than in the ceca. Warthin-Starry stains of cecum and colon revealed dense populations of bacteria in the lumen and glands of affected mice. Bacteria were of mixed morphologic types but most bacteria in the glands were elongated narrow spirals, morphologically compatible with H. mastomyrinus, as previously described 42 (figure 10). Similar organisms were present in unaffected heterozygous mice, but were not associated with inflammation.
Most of the infiltrating inflammatory cells were identified as plasma cells based on morphology and immunoreactivity to IRF-4 but not B220 or F4/80 (figure 11). Immunochemical staining revealed that the remaining mononuclear inflammatory cells were B cells (mostly confined to follicles) with fewer T cells and scattered macrophages (figure 11). In the small intestine, inflammation was absent, but foci of crypt epithelial proliferation were present throughout the duodenum, jejunum, and ileum in telomerase-deficient (figure 12), but not in heterozygous mice (figure 13). These were characterized by increased cell density and increased basophilia with scattered mitotic figures. There were no histologic lesions in stomach, heart, lung, kidney, or liver.
The number of mice affected in each group is indicated in table 4. Of the 79 telomerase-deficient mice examined, all but 10 were affected (87%). Interestingly, of the 10 unaffected mice, 8 were 3 months or less in age, suggesting that older mice were more susceptible to disease or that disease was progressive, becoming worse with age, but this could not be statistically confirmed. None of the heterozygous mice had gross or histologic evidence of typhlocolitis, although helicobacter-like bacteria were present in Warthin-Starry stained sections of cecum and colon (not shown).
Table 4.
Prevalence of typhlocolitis in telomerase deficient mice and heterozygous controls.
| Straina | Total no. | No. affected (%) | Age range (months) |
|---|---|---|---|
| TR-KO | 12 | 12 (100) | 9–13 |
| TR-heterozygous | 8 | 0 | 9–10 |
| TERT-KO | 67 | 57 (85) | 1–13 |
| 3 months or less | 11 | 3 (27) | 1–3 |
| 4 months or more | 56 | 54 (96) | 4–13 |
| TERT-heterozyous | 30 | 0 | 1.5–12 |
TERT = telomerase reverse transcriptase; mTR= murine telomerase RNA; KO=knockout; het=heterozygote
Isolation and identification of H. mastomyrinus
A single species of helicobacter was isolated from affected telomerase-deficient mice, and was identified as H. mastomyrinus on the basis RFLP and sequencing of the 16S rRNA gene. RFLP of genus-specific PCR amplicons from recovered bacteria revealed three bands identical in size to those described for H. mastomyrinus by Shen et al 42, and distinct in size from those of H. hepaticus (figure 14). Sequencing of helicobacter-specific rRNA clones and of PCR amplicons from helicobacter recovered from affected mice revealed a single species of helicobacter in all mice tested. Sequence comparison revealed >99% sequence identity with each other and with the H. mastomyrinus type strains, AY742307 and AY631955, leading to their identification as H. mastomyrinus.
Figure 14.
Restriction-fragment length polymorphism of helicobacter strains. The rRNA gene was PCR amplified and digested with HhaI, and fragments were separated on an agarose gel (see methods) Lane 1: Size markers, Lane 2: H. mastomyrinus isolated from a TERT KO mouse, Lane 3: H. hepaticus 3B1, Lane 4: Cloned H. mastomyrinus rRNA gene from a TERT KO mouse. Approximate band sizes are indicated to the right of the figure.
Recipient RAG KO mice
RAG-KO mice were inoculated with either cecal contents from affected TERT KO mice, pure cultures of H. mastomyrinus from TERT KO mice, or pure cultures of H. hepaticus, and were given CD4+ T cells by adoptive transfer. All recipient mice inoculated with either H. mastomyrinus or cecal contents developed severe typhlocolitis that was clinically similar to disease in naturally-infected TERT KO mice. Mice developed soft stools, and one mouse become moribund and was euthanized 3 weeks after adoptive transfer. All of the remaining mice survived for the 8 week duration of the experiment. Grossly, mice had dilated ceca and colons with thickened walls (figure 15) similar to those of affected TERT KO mice, except that the ceca were somewhat less atrophied in the recipient RAG-KO mice compared to the naturally-infected TERT KO mice. Uninfected recipient RAG KO mice had no gross lesions (figure 16). Histologic lesions differed somewhat between recipient RAG KO mice and naturally-infected telomerase deficient mice. In recipient RAG KO mice, like telomerase deficient mice, typhlocolitis was characterized by marked, widespread infiltration with granulocytes and mononuclear cells, and marked epithelial proliferation (figure 17 ). In recipient RAG KO mice however, mucosa-associated lymphoid follicles were absent, presumably because insufficient numbers of B cells were present in the transferred cell population (see methods). Epithelial dysplasia was absent in infected recipient RAG KO mice (figure 17).
Figure 15–23.
Figure 15. H mastomyrinus-infected recipient RAG KO mouse. Cecum is pale with a thickened wall (arrow).
Figure 16. Uninfected recipient RAG KO mouse. Cecum and colon are normal.
Figure 17. Cecum from a recipient RAG KO mouse inoculated with H. mastomyrinus. There is widespread epithelial proliferation and inflammation, but lymphoid follicles and epithelial dysplasia are absent. HE.
Figure 18. Cecum from a recipient RAG KO mouse inoculated with cecal contents from TERT KO mice. Most lamina propria and submucosal infiltrating cells are immunoreactive for CD3 (a) or F4/80 (b). CD45R (B220) positive cells are rare (c) and IRF-4 positive cells (d) are inapparent. Immunoperoxidase reaction with DAB (a, b, c) or fast red (d ) chromogen and Harris’ hematoxylin counterstain.
Figure 19. Colitis scores in recipient RAG KO mice. Mice were inoculated with helicobacter sp or with cecal contents from TERT KO mice (Hm cecal contents) as described, and given CD4+ enriched T cells by adoptive transfer (see methods). Eight weeks after transfer, tissues were collected and scored histologically as indicated in table 3. Each symbol represents one mouse. NS=Not significant, ANOVA with Bonferroni correction.
Figure 20. Cecum from an IL-10 KO mouse infected with H. mastomyrinus. The epithelium is proliferative and there is moderate mucosal inflammatory infiltrate. Mucosal lymphoid follicles are present. HE.
Figure 21. Cecum from an IL-10 KO mouse infected with H. mastomyrinus showing mixed inflammatory infiltrate and proliferative epithelium. HE.
Figure 22. Cecum from an IL-10 KO mouse infected with H. mastomyrinus. Inflammatory cells consisted of CD3+ T cells (a), a few CD45R (B220)+ B cells (b), many F4/80+ macrophages (c), and scattered IRF-4+ plasma cells (d). Immunoperoxidase reaction with DAB (a, b, c) or AEC (d ) chromogen and Harris’ hematoxylin counterstain.
Figure 23. Typhlitis scores in helicobacter infected IL-10 KO mice. Mice were inoculated as described in the methods, and tissues were scored as indicated in table 3. Each symbol represents one mouse.
The distribution of inflammatory cell types in infected recipient RAG KO mice also differed from that of naturally-infected telomerase-deficient mice. In recipient RAG KO mice, immunochemical identification of cell subsets revealed that most infiltrating mononuclear inflammatory cells were immunoreactive for either CD3 or F4/80 and were negative for IRF-4, indicating that most were T cells or macrophages (figure 18) rather than plasma cells, as in telomerase-deficient mice. Multinucleated cells in these mice were of macrophage origin, as indicated by immunoreactivity for F4/80 but not IRF-4. As indicated in figure 18, only rare cells were immunoreactive for B220 or IRF-4. Because the cell population transferred to these mice was highly enriched in T cells 15 and because recipient mice do not develop either B cell follicles or serum IgG antibody 15, these cells were presumed to be either small numbers of residual cells in the transferred population, or immature cells that cross-reacted with the B and plasma cell markers.
Like H. mastomyrinus-infected mice, recipient RAG KO mice infected with H. hepaticus also developed typhlocolitis, but it was less severe than in mice infected with H. mastomyrinus. This interpretation is based on the observations that gross lesions were not apparent in mice given H. hepaticus; only 2 of 4 mice developed colitis; mean colitis scores were significantly less than in mice given TERT cecal contents; and of the two mice with lesions, scores were less than in mice given either H. mastomyrinus or TERT KO cecal contents (figure 19).
IL-10 KO mice
IL-10 KO mice inoculated with H. mastomyrinus cultured from TERT KO mice developed severe typhlocolitis within 2 weeks of inoculation. Lesions were similar to those in naturally infected TERT KO mice. Grossly, mice had soft stools and thickened, dilated colons and ceca. Inflammation was transmural, was accompanied by epithelial proliferation and mucosal lymphoid follicles (figure 20), and was characterized by lymphocytes, macrophages, and neutrophils (figure 21). As in the RAG KO mice, most of the infiltrating cells were identified by immunochemistry as macrophages with fewer T cells, B cells, and plasma cells (figure 22). Multinucleated giant cells were rarely present. As in TERT KO mice, mucosa-associated lymphoid nodules were prominent, but as in recipient RAG KO mice, focal epithelial dysplasia was absent. Small intestine was normal in IL-10 KO mice.
In contrast to mice inoculated with H. mastomyrinus, H. hepaticus-infected IL-10 KO mice developed minimal to mild typhlocolitis, even by 27 days after inoculation. Typhlitis scores in H. mastomyrinus-infected mice were significantly greater than scores in H. hepaticus-infected mice, which were not significantly different from uninfected mice (figure 23). H. hepaticus and H. mastomyrinus-infected C57BL/6 control mice had no gross or histologic lesions.
Discussion
The major findings of this study are 1) that telomerase-deficient mice are susceptible to helicobacter-associated typhlocolitis, 2) that H. mastomyrinus is potentially pathogenic in susceptible mouse strains, and 3) that H. mastomyrinus is more pathogenic than H. hepaticus in two models of IBD.
Lower bowel helicobacters are a common contaminant of laboratory mouse colonies. They do not cause disease in most inbred strains, but have been associated with inflammatory bowel lesions in a number of strains of mutant mice. H. hepaticus, the most commonly identified murine helicobacter and the best studied, was first identified in association with hepatitis and hepatocellular carcinoma in male A/J mice 50,53, and was subsequently shown to be associated with inflammatory bowel disease in several mutant mouse strains 8,9,16,18,29,31,51. Subsequently, several other species of lower bowel helicobacters have been associated with IBD in susceptible mouse strains 11,20,25,43,44,54,58. Their direct role in disease remains controversial, however. In some studies of IBD in mice, helicobacter species were not identified 13,21 and bacterial genera other than helicobacter have been associated with bowel inflammation in mice 2. Some authors have suggested that murine lower bowel helicobacters may cause disease indirectly by inducing damaging host responses to co-colonizing enteric organisms 24. Thus, it is likely that factors in addition to than helicobacter contribute to disease, and that helicobacter species are one of several members of the indigenous murine microbiota that cause or exacerbate inflammatory lesions in susceptible mouse strains.
H. mastomyrinus was originally isolated from a multimammate rat (Mastomys natalensis) and a colony of laboratory mice 42. It has subsequently been identified in several mouse colonies 6,47, but its pathogenicity in helicobacter-susceptible mouse strains was not evaluated. In the current study, we demonstrated that H. mastomyrinus isolated from mice with typhlocolitis induced lower bowel inflammation in two commonly studied models of helicobacter-associated inflammatory bowel disease, thus demonstrating its pathogenic potential. Furthermore, in recipient RAG KO mice lesions due to H. mastomyrinus were significantly more severe than those due to H. hepaticus, suggesting that helicobacter species may differ in their pathogenic potential, and that H. mastomyrinus is more pathogenic that H. hepaticus.
Differences in pathogenicity of different helicobacter species have been described previously. One study found small differences in pathogenicity of H. hepaticus and H. bilis in 2 different mouse models 7. In another study, H. typhlonius was found to be more pathogenic than H. rodentium in IL-10 KO mice, and the combination of two strains more pathogenic still 11. In recipient RAG-KO mice, H. hepaticus was shown to be more pathogenic than H. ganmanii 58. Conversely, in a different model H. hepaticus was associated with amelioration of disease, while H. bilis was associated with exacerbation 33. Thus, the reported outcome of infection by lower bowel helicobacters varies markedly among different studies. It is likely that pathogenicity varies according to both the helicobacter species and the characteristics of the mouse model used, and that environment, host, and bacterial factors all contribute to the extent of disease.
In this study, H. mastomyrinus caused severe typhlocolitis in all three mouse strains. Differences in infiltrating cell types is likely attributable to the specific immunologic defect of the individual models. Recipient RAG KO mice lack functional B cells 15 and regulatory T cells 38 compatible with the absence of lymphoid follicles, and the large number of T cells and macrophages in the inflammatory infiltrate. IL-10 KO mice are defective in immunoregulation, likely accounting for T cells and macrophages in the infiltrate, but they do have functional B cells and developed mucosal lymphoid follicles as did the telomerase-deficient mice. The specific immunologic defects in telomerase deficient mice is not yet known, but the large number of plasma cells and B cell follicles may implicate T cell or regulatory cell dysfunction.
The current study is, to our knowledge, the first to describe helicobacter-associated typhlocolitis in telomerase-deficient mice, and the pathogenesis of disease in this mouse strain is not yet known. Comparison with similar mouse models of helicobacter-associated IBD, however, strongly implicates immune dysfunction, epithelial dysfunction, or both as common pathways to lower bowel inflammation. As noted above, the IL-10 KO and recipient RAG KO models are the best studied of the mouse models of helicobacter-associated IBD. However, many other mouse strains are susceptible to inflammatory disease of the lower bowel, and a number of different models have been used to examine various aspects of IBD pathogenesis (for reviews see 46). These models differ markedly in mouse background strain, mutation, and experimental manipulation, but there are some common factors, notably that the functional defect responsible for inflammation is either failure of immunoregulation, damage to the epithelial barrier function, or both. In the models used in the current study, disease has been attributed to dysfunction (IL-10 KO) 46 or absence (recipient RAG KO) 45 of regulatory T cells, leading to a dysregulated hyper-inflammatory response to a member of the enteric microbiota. Similarly, mice that are deficient in IL-2, IL-2 receptor, or TGFβ are associated with failure of immunoregulation and IBD, while TNFα and T-bet overexpressing mice develop inflammation presumably due to a hyperinflammatory state. In a few models, such as the multi-drug resistant (MDR) mice and glutathione peroxidase (GPX) deficient mice, disease has been attributed to leakiness of the intestinal epithelial barrier, presumably allowing contact of proinflammatory luminal contents with immune cells in the lamina propria 46.
Either immune or epithelial defects could contribute to IBD in telomerase-deficient mice. Several studies have described immunologic abnormalities that could lead to immune dysfunction in association with lack of telomerase. In both humans and mice, telomerase deficiency leads to abnormal development of bone marrow stem cells, and can lead to defects in hemopoietic cells 4,26. Telomerase deficient mice have fewer T cells and B cells than C57BL/6 controls, and their lymphocytes are less responsive to stimulation in vitro 23,30, suggesting that immune dysfunction is one outcome of telomerase loss. Indirectly, aging studies also implicate telomerase in immunodysfuction and chronic inflammation. Telomere shortening with increasing age has been observed in all cells of the immune system 26, and has been associated with various functional defects of immunosenescence including failure of immune responses 34,56, chronic inflammation 41, and decreased ratio of regulatory:effector T cells 39. Thus, although immune function in telomerase-deficient mice has been incompletely described as yet, evidence suggests that it could contribute to chronic inflammatory disease in response to enteric bacteria.
Intestinal epithelial abnormalities have also been described in telomerase deficient mice, and could contribute to IBD susceptibility, at least in part. In the current study, we described multifocal adenomatous proliferation in the small intestine of TERT and TR KO mice, as well as proliferation and dysplasia in the colon and cecum. Similar proliferative lesions have been previously described in telomerase deficient mice 22,23. Their pathogenesis is not known, but lack of telomerase is associated with chromosomal instability, particularly in rapidly dividing cell populations and it is possible that such instability could result in enhanced susceptibility to helicobacter-induced damage and thus predispose to disease. In fact, ulcerative colitis has been associated with short telomeres in humans 36, although the mechanism is not known. Also, mice that overexpress the TERT component of telomerase have increased resistance to DSS-induced colitis, supporting the possibility that absence of telomerase activity renders intestinal epithelia more susceptible to injury 48.
In summary, our unexpected finding that telomerase deficiency enhances susceptibility to helicobacter-induced inflammatory bowel disease strengthens support for the growing consensus that screening for and elimination of lower bowel helicobacters is necessary to protect genetically engineered mice from disease 3,10,19. We further showed that even when H. hepaticus is not present, other helicobacter species can contribute to naturally-occurring disease in mouse colonies, and may induce even more severe lesions than the more commonly isolated helicobacters. Finally, we provide preliminary evidence that telomerase deficiency may lead to immunologic or intestinal epithelial dysfunction that could lead to increased susceptibility to disease of the lower bowel.
Acknowledgments
This study was supported in part by Public Health Service grants R01 AI043643 (KAE) and R01 DK070875 (VBY) from the NIH. The authors thank Paula Arrowsmith and Carrie Schray for outstanding technical assistance with the immunohistochemical staining.
References
- 1.Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun. 2009;77:2367–2375. doi: 10.1128/IAI.01520-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Balish E, Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol. 2002;160:2253–2257. doi: 10.1016/S0002-9440(10)61172-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Barthold SW. Genetically altered mice: phenotypes, no phenotypes, and Faux phenotypes. Genetica. 2004;122:75–88. doi: 10.1007/s10709-004-1439-3. [DOI] [PubMed] [Google Scholar]
- 4.Blasco MA. Telomere length, stem cells and aging. Nat Chem Biol. 2007;3:640–649. doi: 10.1038/nchembio.2007.38. [DOI] [PubMed] [Google Scholar]
- 5.Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 1997;91:25–34. doi: 10.1016/s0092-8674(01)80006-4. [DOI] [PubMed] [Google Scholar]
- 6.Bohr UR, Selgrad M, Ochmann C, Backert S, Konig W, Fenske A, Wex T, Malfertheiner P. Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility. J Clin Microbiol. 2006;44:738–742. doi: 10.1128/JCM.44.3.738-742.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Burich A, Hershberg R, Waggie K, Zeng W, Brabb T, Westrich G, Viney JL, Maggio-Price L. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2001;281:G764–778. doi: 10.1152/ajpgi.2001.281.3.G764. [DOI] [PubMed] [Google Scholar]
- 8.Cahill RJ, Foltz CJ, Fox JG, Dangler CA, Powrie F, Schauer DB. Inflammatory bowel disease: An immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun. 1997;65:3126–3131. doi: 10.1128/iai.65.8.3126-3131.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Cahill RJ, Foltz CJ, Fox JG, Li X, Schauer DB. Influence of the murine pathogen Helicobacter hepaticus on development of inflammatory bowel disease in immunocompromised mice. Gastroenterology. 1996 [Google Scholar]
- 10.Chichlowski M, Hale LP. Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies. Comp Med. 2009;59:10–17. [PMC free article] [PubMed] [Google Scholar]
- 11.Chichlowski M, Sharp JM, Vanderford DA, Myles MH, Hale LP. Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice. Comp Med. 2008;58:534–541. [PMC free article] [PubMed] [Google Scholar]
- 12.Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, Kulam-Syed-Mohideen AS, McGarrell DM, Marsh T, Garrity GM, Tiedje JM. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 2009;37:D141–145. doi: 10.1093/nar/gkn879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Duchmann R, Schmitt E, Knolle P, Meyer zum Buschenfelde KH, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol. 1996;26:934–938. doi: 10.1002/eji.1830260432. [DOI] [PubMed] [Google Scholar]
- 14.Eaton KA, Benson LH, Haeger J, Gray BM. Role of transcription factor T-bet expression by CD4+ cells in gastritis due to Helicobacter pylori in mice. Infect Immun. 2006;74:4673–4684. doi: 10.1128/IAI.01887-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Eaton KA, Mefford M, Thevenot T. The Role of T Cell Subsets and Cytokines in the Pathogenesis of Helicobacter pylori Gastritis in Mice. J Immunol. 2001;166:7456–7461. doi: 10.4049/jimmunol.166.12.7456. [DOI] [PubMed] [Google Scholar]
- 16.Foltz CJ, Fox JG, Cahill R, Murphy JC, Yan L, Shames B, Schauer DB. Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter. 1998;3:69–78. doi: 10.1046/j.1523-5378.1998.08006.x. [DOI] [PubMed] [Google Scholar]
- 17.Fox JG, Li X, Yan L, Cahill RJ, Hurley R, Lewis R, Murphy JC. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis. Infect Immun. 1996;64:1548–1558. doi: 10.1128/iai.64.5.1548-1558.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Fox JG, Yan L, Shames B, Campbell J, Murphy JC, Li X. Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect Immun. 1996;64:3673–3681. doi: 10.1128/iai.64.9.3673-3681.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Franklin CL. Microbial considerations in genetically engineered mouse research. ILAR journal. 2006;47:141–155. doi: 10.1093/ilar.47.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Franklin CL, Riley LK, Livingston RS, Beckwith CS, Hook RR, Jr, Besch-Williford CL, Hunziker R, Gorelick PL. Enteric lesions in SCID mice infected with “Helicobacter typhlonicus,” a novel urease-negative Helicobacter species. Lab Anim Sci. 1999;49:496–505. [PubMed] [Google Scholar]
- 21.Gaskins HR, Vondrakjuergens GL, Mccracken BA, Woolsey JH. Specific-pathogen-free conditions enhance inflammatory bowel disease in T-cell receptor knockout, but not C3H/HeJBir mice. Lab Anim Sci. 1997;47:650–655. [PubMed] [Google Scholar]
- 22.Hao L-Y, Armanios M, Strong MA, Karim B, Feldser DM, Huso D, Greider CW. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell. 2005;123:1121–1131. doi: 10.1016/j.cell.2005.11.020. [DOI] [PubMed] [Google Scholar]
- 23.Herrera E, Samper E, Martín-Caballero J, Flores JM, Lee HW, Blasco MA. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 1999;18:2950–2960. doi: 10.1093/emboj/18.11.2950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Jergens AE, Wilson-Welder JH, Dorn A, Henderson A, Liu Z, Evans RB, Hostetter J, Wannemuehler MJ. Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut. 2007;56:934–940. doi: 10.1136/gut.2006.099242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Jiang HQ, Kushnir N, Thurnheer MC, Bos NA, Cebra JJ. Monoassociation of SCID mice with Helicobacter muridarum, but not four other enterics, provokes IBD upon receipt of T cells. Gastroenterology. 2002;122:1346–1354. doi: 10.1053/gast.2002.32959. [DOI] [PubMed] [Google Scholar]
- 26.Kaszubowska L. Telomere shortening and ageing of the immune system. J Physiol Pharmacol. 2008;59(Suppl 9):169–186. [PubMed] [Google Scholar]
- 27.Kuehl CJ, Wood HD, Marsh TL, Schmidt TM, Young VB. Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect Immun. 2005;73:6952–6961. doi: 10.1128/IAI.73.10.6852-6961.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Kullberg MC, Jankovic D, Gorelick PL, Caspar P, Letterio JJ, Cheever AW, Sher A. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med. 2002;196:505–515. doi: 10.1084/jem.20020556. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, Jankovic D, Sher A. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun. 1998;66:5157–5166. doi: 10.1128/iai.66.11.5157-5166.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho RA. Essential role of mouse telomerase in highly proliferative organs. Nature. 1998;392:569–574. doi: 10.1038/33345. [DOI] [PubMed] [Google Scholar]
- 31.Li X, Fox JG, Whary MT, Yan L, Shames B, Zhao Z. SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis. Infect Immun. 1998;66:5477–5484. doi: 10.1128/iai.66.11.5477-5484.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Liu T, Chung MJ, Ullenbruch M, Yu H, Jin H, Hu B, Choi YY, Ishikawa F, Phan SH. Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice. J Clinl Invest. 2007:1–10. doi: 10.1172/JCI32369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Maggio-Price L, Shows D, Waggie K, Burich A, Zeng W, Escobar S, Morrissey P, Viney JL. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a−/−) mice. Am J Pathol. 2002;160:739–751. doi: 10.1016/S0002-9440(10)64894-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Maue AC, Yager EJ, Swain SL, Woodland DL, Blackman MA, Haynes L. T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol. 2009;30:301–305. doi: 10.1016/j.it.2009.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Nagata K, Takagi E, Tsuda M, Nakazawa T, Satoh H, Nakao M, Okamura H, Tamura T. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: Inhibition of growth is not related to inhibition of urease. Antimicrob Agents Chemother. 1995;39:567–570. doi: 10.1128/aac.39.2.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.O’Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen W-T, Emerson S, Emond MJ, Gollahon KA, Moskovitz AH, Crispin DA, Potter JD, Rabinovitch PS. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet. 2002;32:280–284. doi: 10.1038/ng989. [DOI] [PubMed] [Google Scholar]
- 37.Pratt JS, Sachen KL, Wood HD, Eaton KA, Young VB. Modulation of Host Immune Responses by the Cytolethal Distending Toxin of Helicobacter hepaticus. Infect Immun. 2006;74 doi: 10.1128/IAI.00503-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Raghavan S, Holmgren J. CD4(+)CD25(+) suppressor T cells regulate pathogen induced inflammation and disease. FEMS Immunol Med Microbiol. 2005;44:121–127. doi: 10.1016/j.femsim.2004.10.017. [DOI] [PubMed] [Google Scholar]
- 39.Rappl G, Schmidt A, Mauch C, Hombach AA, Abken H. Extensive amplification of human regulatory T cells alters their functional capacities and targets them to the periphery. Rejuvenation Res. 2008;11:915–933. doi: 10.1089/rej.2008.0723. [DOI] [PubMed] [Google Scholar]
- 40.Sacco R, Haynes J, Harp J, Waters W, Wannemuehler M. Cryptosporidium parvum initiates inflammatory bowel disease in germfree T cell receptor-alpha-deficient mice. Amer J Pathol. 1998;153:1717–1722. doi: 10.1016/s0002-9440(10)65686-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Sarkar D, Fisher PB. Molecular mechanisms of aging-associated inflammation. Cancer Lett. 2006;236:13–23. doi: 10.1016/j.canlet.2005.04.009. [DOI] [PubMed] [Google Scholar]
- 42.Shen Z, Xu S, Dewhirst FE, Paster BJ, Pena JA, Modlin IM, Kidd M, Fox JG. A novel enterohepatic Helicobacter species ‘Helicobacter mastomyrinus’ isolated from the liver and intestine of rodents. Helicobacter. 2005;10:59–70. doi: 10.1111/j.1523-5378.2005.00292.x. [DOI] [PubMed] [Google Scholar]
- 43.Shomer NH, Dangler CA, Marini RP, Fox JG. Helicobacter bilis/Helicobacter rodentium co-infection associated with diarrhea in a colony of scid mice. Lab Anim Sci. 1998;48:455–459. [PubMed] [Google Scholar]
- 44.Shomer NH, Dangler CA, Schrenzel MD, Fox JG. Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora. Infect Immun. 1997;65:4858–4864. doi: 10.1128/iai.65.11.4858-4864.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Singh B, Read S, Asseman C, Malmström V, Mottet C, Stephens LA, Stepankova R, Tlaskalova H, Powrie F. Control of intestinal inflammation by regulatory T cells. Immunol Rev. 2001;182:190–200. doi: 10.1034/j.1600-065x.2001.1820115.x. [DOI] [PubMed] [Google Scholar]
- 46.Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol. 2002;20:495–549. doi: 10.1146/annurev.immunol.20.100301.064816. [DOI] [PubMed] [Google Scholar]
- 47.Taylor NS, Xu S, Nambiar P, Dewhirst FE, Fox JG. Enterohepatic Helicobacter species are prevalent in mice from commercial and academic institutions in Asia, Europe, and North America. J Clin Microbiol. 2007;45:2166–2172. doi: 10.1128/JCM.00137-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Tomás-Loba A, Flores I, Fernández-Marcos PJ, Cayuela ML, Maraver A, Tejera A, Borrás C, Matheu A, Klatt P, Flores JM, Viña J, Serrano M, Blasco MA. Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell. 2008;135:609–622. doi: 10.1016/j.cell.2008.09.034. [DOI] [PubMed] [Google Scholar]
- 49.Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73:5261–5267. doi: 10.1128/AEM.00062-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Ward JM, Anver MR, Haines DC, Benveniste RE. Chronic active hepatitis in mice caused by Helicobacter hepaticus. Amer J Pathol. 1994;145:959–968. [PMC free article] [PubMed] [Google Scholar]
- 51.Ward JM, Anver MR, Haines DC, Melhorn JM, Gorelick P, Yan L, Fox JG. Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab Anim Sci. 1996;46:15–20. [PubMed] [Google Scholar]
- 52.Ward JM, Erexson CR, Faucette LJ, Foley JF, Dijkstra C, Cattoretti G. Immunohistochemical markers for the rodent immune system. Toxicologic Path. 2006;34:616–630. doi: 10.1080/01926230600941340. [DOI] [PubMed] [Google Scholar]
- 53.Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ, Jr, Gorelick PL, Nagashima K, Gonda MA, Gilden RV, et al. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst. 1994;86:1222–1227. doi: 10.1093/jnci/86.16.1222. [DOI] [PubMed] [Google Scholar]
- 54.Whary MT, Danon SJ, Feng Y, Ge Z, Sundina N, Ng V, Taylor NS, Rogers AB, Fox JG. Rapid onset of ulcerative typhlocolitis in B6.129P2-IL10tm1Cgn (IL-10−/−) mice infected with Helicobacter trogontum is associated with decreased colonization of Altered Schaedler’s Flora. Infect Immun. 2006 doi: 10.1128/IAI.01091-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Wirtz S, Neurath MF. Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int J Colorectal Dis. 2000;15:144–160. doi: 10.1007/s003840000227. [DOI] [PubMed] [Google Scholar]
- 56.Wu D, Meydani SN. Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention. J Leukoc Biol. 2008;84:900–914. doi: 10.1189/jlb.0108023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Yuan X, Ishibashi S, Hatakeyama S, Saito M, Nakayama J, Nikaido R, Haruyama T, Watanabe Y, Iwata H, Iida M, Sugimura H, Yamada N, Ishikawa F. Presence of telomeric G-strand tails in the telomerase catalytic subunit TERT knockout mice. Genes Cells. 1999;4:563–572. doi: 10.1046/j.1365-2443.1999.00284.x. [DOI] [PubMed] [Google Scholar]
- 58.Zhang L, Danon SJ, Grehan M, Chan V, Lee A, Mitchell H. Natural colonization with Helicobacter species and the development of inflammatory bowel disease in interleukin-10-deficient mice. Helicobacter. 2005;10:223–230. doi: 10.1111/j.1523-5378.2005.00314.x. [DOI] [PubMed] [Google Scholar]



